Articles
1 articles available
Filko Prugo, Matthew Rizzolo, Henry Huang (Ropes & Gray LLP), Charlotte Jacobsen (Gibson, Dunn & Crutcher LLP)
January 29, 2019
For manufacturers of biologics and biosimilars facing potential patent litigation in the U.S., the Biologics Price Competition and Innovation Act (BPCIA) imposes a complex statutory scheme that…